体内
病毒学
病毒
生物
抗体
单克隆抗体
干扰素
Sars病毒
机制(生物学)
免疫系统
甲型流感病毒
呼吸系统
免疫学
2019年冠状病毒病(COVID-19)
病毒复制
荧光素酶
作用机理
抗体反应
脂多糖
高致病性
特异性抗体
体外
生物活性
药理学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
作者
Cheng-long Chen,Murong Zhu,Ya'nan Li,Jiayu Jiang,Jing Ma,Lingyuan Fan,Jiarong Zhao,Jingjing Ma,Ruijie Jiang,Qinghua Cui,Lijun Rong,Ruikun Du
摘要
ABSTRACT Yupingfeng (YPF) is a classic formula of traditional Chinese medicine and has been widely used to prevent and treat respiratory virus infectious diseases. However, the pharmacological mechanism underlying the antiviral activity of YPF remains elusive. In the present study, we evaluated the ability of YPF to promote type I interferon (IFN‐I) production in vitro, subsequently inducing expression of numerous interferon‐stimulated genes that exert antiviral activities. In addition, by employing an advanced bioluminescence imaging‐based mouse model of influenza virus infection, we monitored the alteration of viral kinetics in vivo upon YPF treatment in real time. As a result, our findings demonstrated that YPF predominantly reduces the viral load in animals at later stages of infection. Further mechanistic studies suggested that YPF can especially enhance the Th2 polarization and IgG1 antibody response, accelerating the elimination of invading viruses. Our study provides consolidated evidence for the antiviral properties of YPF and will facilitate its clinical use and further development.
科研通智能强力驱动
Strongly Powered by AbleSci AI